N/A
Completed N=125
E-Visit for COPD and Smoking Cessation
Pulmonary Disease, Chronic Obstructive · Cigarette Smoking · Telemedicine
Source: ClinicalTrials.gov NCT04155073 ↗
Enrolled (actual)
125
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcomePrimary: Evidence-based Cessation Treatment Utilization — 44; 10; 51; 11 Participants
Summary
The goal of this work is to develop, refine, and pilot test an electronic visit (e-visit) to: 1) deliver smoking cessation treatment to adults at risk for COPD and 2) to improve rates of COPD early detection and accurate diagnosis. The investigators will conduct a pilot RCT of the COPD/smoking cessation e-visit as compared to treatment as usual (TAU), with primary objective to provide effect size estimates for a larger RCT.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Evidence-based Cessation Treatment Utilization |
44; 10; 51; 11 | — |
| PRIMARY Number of Participants at Month 1 and Month 3 With At Least 1 Quit Attempt |
20; 6; 24; 13 | — |
| SECONDARY E-visit Acceptability and Feasibility |
— | — |
Eligibility Criteria
Inclusion Criteria
- current cigarette smoker,
- enrolled in MUSC's Epic MyChart program or willing to sign up for MyChart,
- possess a valid e-mail address that is checked daily,
- English fluency, and
- owner of an iOS or Android-compatible smartphone and a webcam-enabled device
Exclusion Criteria
- COPD on a patient's problem list within Epic.
Data sourced from ClinicalTrials.gov (NCT04155073). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.